Top 50 Biotechnology Startup Investors in Sweden in October 2023

Portfolio highlights

• Encare — Encare was established in 2009 to implement the ERAS Protocols on a global basis by- providing training to health care professionals on the ERAS Protocols- providing an interactive and web-based information system for evidence based - best practice management (EBM)The company has developed an interactive, user-friendly interface forthe collection, documentation and follow-up on critical performance and quality parameters as lined out by leading clinical experts in respective protocol[1] based on, at any time, best practice and evidence.The data collected in the web-based solution is interactive and offers immediate feedback of performance, which will generate significant and sustainable improvement of efficiency and quality of care as well as generate substantial health care savings.Encare has the rights to commercialize surgical protocols developed by the ERAS Society. The company has so far rolled out the audit system to more than 120 hospitals in Canada, France, Norway, Poland, Sweden, South Africa, Switzerland, the United Kingdom, Argentina, Mexico, Colombia, Brazil, Singapore and the United States.The ERAS Society was formed in 2001 with the aim to establish evidence based protocols as best practice standards in perioperative care. ERAS Society has published a wide range of publications regarding protocols and guidelines for enhanced recovery after surgery.
• PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
• Capitainer — Quantitative microsampling solutions for diagnostics, research and clinical trials. Microsampling you can trust.

Portfolio highlights

• Adsorbi — Adsorbi develops a novel biomaterial based on cellulose.
• RadChat — RadChat is a method for arranging timeslots between cars in close proximity. The timeslots can then be used for radar sensing or for transmitting data to nearby cars through the radar unit.The patent-pending technology's ability to eliminate radar interference is unequaled. Because each car in the vicinity has its own assigned timeslot,there will be no interference from other vehicles. RadChat enables your vehicle's sensors to be trusted.The data communication utility is a supplementary technology for communication in scenarios requiring low latency, directed connectivity, and safety. Video feeds, vital safety alarms, location and positioning data, and other types of data can be delivered.
• EmbeDL — Efficient Deep Learning for Embedded Systems

Portfolio highlights

• Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
• Retein — Aquammodate is a greentech company that produces highly pure water at minimum energy cost.
• Open Payments — Open Payments connects you to multiple banks through one single unified API. This removes the complexity and frictions of many diverse integrations

Portfolio highlights

• Dicot — Dicot is a pharmaceutical company focused on drug discovery and the development of novel lifestyle drugs to enrich patients' lives. The Company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in the pre-clinical stage of development.
• EmbeDL — Efficient Deep Learning for Embedded Systems
• Nordic Forestry Automation — The forestry sector is standing before unprecedented challenges in adapting to increased demand for sustainable raw materials, carbon storage, biodiversity conservation and a shortage of highly skilled machine operators. Digital tools, precision forestry and automation will play a crucial role in

Portfolio highlights

• AlixLabs — AlixLabs is an innovative startup enabling the semiconductor industry to scale down in a cost effective manner
• EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
• Retein — Aquammodate is a greentech company that produces highly pure water at minimum energy cost.

Portfolio highlights

• Henlez — Henlez is a Danish startup company.
• OssDsign AB — OssDsign was founded in May 2011 by Professor Håkan Engqvist, Dr Thomas Engstrand, Bo Qwarnstrom, Jonas Åberg, Uppsala University AB and other leading clinical, preclinical and materials researchers and engineers. The key people in the company are presented below. OssDsign has in addition developed a network of international experts in ClinicalAffairs, Regulatory and Business Development.
• Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.

Portfolio highlights

• Airsonett — Research-based medical technology company which leads the way in the development of non-pharmaceutical treatment for allergic asthma.
• EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
• Qvantum — Qvantum is driven by a passion for a sustainable future, built by a team of industry experts, and using groundbreaking innovation.

Portfolio highlights

• Hemab — Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
• ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
• Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.

Portfolio highlights

• LanguifyAI — Languify is an AI based language learning assistant which analyses, corrects, and tracks a user's spoken and written English across all platforms. The AI assistant prompts feedback and nudges that improve conversations in real-time that enable improvisation on the spot without any delay. It also enables users to learn at their own pace throughpersonalized learning plans and games designed to minimize repetition of errors.
• Granular Energy — Granular Energy provides solutions for managing and trading clean energy. Our tools have been developed to support the recent emergence of 24/7 time-stamped energy certificates as well as traditional "annual" certificates.
• Material Evolution — Material Evolution uses patented geopolymer technology and proprietary algorithms to create the most sustainable materials on the planet.Material Evolution’s first product is a cement mix made from 95% waste using its algorithm technology. Its smart concrete mix is 10X stronger, 5X more durable, and reduces carbon consumption by 85%. Mostimportantly, it’s economically viable for construction companies.

Portfolio highlights

• Embla — Embla provides an online medical weight loss treatment using prescription drugs and coaching. The company provides patients with evidence-based treatments, digital tools, medication, and coaching to facilitate sustainable weight loss. Embla was founded in 2021 and is headquartered in Copenhagen, Denmark.
• SNERPA Power — SNERPA Power develops intelligent energy services.
• Ellie.ai — Grasp your business needs and validate your product ideas before building your data pipelines. Use Ellie's conceptual data models and logical data models to design great data products.

Portfolio highlights

• Haltian — End-to-end IoT solutions and world-glass product design services from Haltian
• Commsignia — Commsignia specializes in the research and development, manufacturing and distribution of cooperative intelligent transportation systems. Its product line includes a V2X Communication Software Stack and Commsignia’s own security stack implementation, Hybrid V2X/ADAS Safety Applications, a V2X Simulator, On-Board Units (OBU) and Roadside Units(RSU).The company was founded in 2012 and is headquartered in Santa Clara, California.
• Value.Space — Space based risk assessments & monitoring

Portfolio highlights

• basys.ai — Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies using machine learning, thus reducing the piloting timeline by up to 9 months.
• Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
• ALFIE — AI software platform that provides consistent and automated measurements from radiographic images used to assess spinal disorders.

Portfolio highlights

• Ribbon Biolabs — Ribbon Biolabs revolutionary technology for the fast and efficient automated synthesis of DNA is here to enable the new wave of biotechnological innovation.
• Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
• TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.

Portfolio highlights

• Mylla — Mylla is a digital marketplace for buying and selling food from farm to table.
• Lingio — Lingio is driven by the vision of making language learning more fun! By combining gaming principles, social and education they are providing a truly fun experience to their users.
• SNERPA Power — SNERPA Power develops intelligent energy services.

Portfolio highlights

• Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
• Epishine — Epishine's goal is to be able to provide the world's most scalable, resource efficient, and affordable solar modules. Epishine sells light energy harvesting modules to manufacturers of wireless products. The modules are used to harvest light in any lighting conditions, turning light into usable power.
• LunaMicro — Technology company developing textile pumps based on electroosmosis and conducting polymers for a wide variety of applications including outdoor clothing, PPE, and medicine.

Portfolio highlights

• Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative proximity ligation assay -based solutions for spatial proteomics.
• Allurion Technologies — Allurion Technologies is developing a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
• Signifier Medical Technologies — Driving Innovation in the Sleep MarketSignifier Medical Technologies (SMT) is a medical technology company focused on the development and commercialisation of innovative and non-invasive solutions for patients with sleep-disordered breathing conditions and snoring. Pioneers in challenging the wisdom of conventional sleep apnoea and snoring treatments, we've created the first daytime therapy that tackles the root cause of sleep-disordered breathing by physiologically retraining the airway against collapse.

Portfolio highlights

• Octave — Octave is a national behavioral health practice that’s creating a new standard for care delivery that’s both high-quality and accessible to more people. With in-person and virtual clinics in California and New York, the company offers personalized care plans that can include individual therapy, couples therapy, and groups, while pioneeringrelationships with payers to make care more affordable through insurance. Grounded in science, Octave enables clients to experience profound change that is as measurable as it is meaningful.
• Acesion Pharma — Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
• Alentis Therapeutics — Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases.

Portfolio highlights

• Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
• Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
• Alba Health — Discover your baby's gut health & microbiome for the best start in life.

Portfolio highlights

• Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
• Natural Cycles — Natural Cycles birth control is 93% effective with typical use and 98% effective with perfect use. Learn more about hormone-free birth control today.
• Kyra — Kyra is a Gen-Z entertainment company creating engaging digital content that resonates with youth culture. We represent world class digital native talent, produce digital content with the biggest and best consumer brands and develop media properties publishing daily content on platforms that matter to Gen Z. Kyra has the ability to not onlytarget but truly engage with the Gen-Z audience through content that resonates based on real-time audience data from our proprietary KyraIQ technology. Our inclusive, ahead-of-the-trend content and content creators make us the ultimate destination for the Gen-Z consumer who wants to be inspired by their own community. Our approach and creativity is based on data and insights and has proven to engage this audience better than any traditional publisher. We house a talent agency representing and collaborating with the leading Gen Z social stars such as Abby Roberts and Noen Eubanks; a global content studio creating award-winning content for youth-seeking brand partners such as Converse and HP; and a newly developed portfolio of media properties publishing daily content on Gen Z-native platforms around beauty, fashion, adventure, food, gaming and entertainment.Kyra engages Gen Z better than any traditional publisher, with an audience of 78 million social media followers racking up 750 million monthly video views in 190 countries around the globe. We know exactly where Gen Z is spending their time online and we respect their interests and passions. That result is content that is meaningful and fosters long term engagement for blue chip brands. Our team are experts on Gen Z culture, whether they are producing, managing, creating or marketing in New York, London and Los Angeles. Learn more at https://kyra.com/reel

Portfolio highlights

• Orthox Ltd. — Founded to commercialise technology developed at Oxford University, Orthox aims to revolutionise the way cartilage injuries are treated. Trauma and erosion of the smooth, stiff cartilage in our joints leads to Osteoarthritis (OA) a debilitating disease, which affects over 300 million patients globally and costs the US economy alone over $128billion each year. Current therapies to repair damaged cartilage focus either on tissue regeneration or on functional replacement; Orthox’s exceptionally strong, resilient, regenerative hydrogel technology, FibroFix™ achieves both these goals, offering a unique solution for the millions of patients suffering from damage to their joints. Initially targeting the knee, Orthox has developed a compelling set of data on lead product FibroFix™ Cartilage which has secured major awards from multiple funding bodies and will shortly enter clinical trials. FibroFix™ technology will then be rolled out to treat other joints and Orthox also has pipeline developments beyond orthopaedics in which strength and tissue regeneration are key. Pipeline expansion is valuable as growth in the annual global biomaterials market will exceed $250 billion by 2025. Orthopaedic biomaterials will form the largest proportion of this and natural biomaterials, like FibroFix™, will be the fastest growing market segment. Orthox: Reducing Pain, Increasing Mobility, Regenerating Strength™.
• Gedea Biotech — Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as wellas providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.
• Oxford Endovascular — Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.This diverts the blood away from the aneurysm, allowing it to heal.

Portfolio highlights

• SAGA Diagnostics — SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine,provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
• Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.

Portfolio highlights

• Valmet — Valmet is the leading global developer and supplier of technologies, automation and services for the pulp, paper and energy industries.
• CTP — CTP NV is a real estate company that owns and develops industrial and logistics parks.
• Cofina Ivory — Cofina Ivory is a savings and credit institution that operates in the sector of mesofinance.

Portfolio highlights

• Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
• ByoWave — ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
• Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.

Portfolio highlights

• Definiens — Definiens is the provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived fromother sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and supports better decisions in research, diagnostics and therapy. Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients’ lives. Definiens is headquartered in Munich, Germany, and has offices throughout the United States.
• Lamab Biologics — Lamab Biologics operates as a biotechnology company. Lamab Biologics develop first-in-class monoclonal antibody prophylactic therapeutic targeting IgE, a key mediator for allergic diseases.
• Rapid Micro Biosystems — Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to RapidMicro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.

Portfolio highlights

• Prion — Prion makes it quick and easy for the preschool staff to give parents insight into what happens at preschool - together with the children. The app is available free for iPhone, Android and iPad.
• Texelio — Texelio a company who is set to redefine financial market news by developing AI which empowers the customers of Retail banks, Online Brokers and Investment Service platforms.
• Minnemera — Minnemera develops digital neurocognitive tests.

Portfolio highlights

• Prog.AI — Prog.AI helps to find developers based on their technical proficiency, libraries they have used, or even just the contributions they have made to GitHub projects.
• Red Flag — Red Flag develops an automated accounting, expenses, and invoicing platform for SMEs.
• Single Technologies — Founded in Stockholm, Sweden, with its long tradition in fiber optics, ultra-sensitive fluorescence spectroscopy and DNA sequencing, SINGLE’s ambition is to become the instigator of 3-D Sequencing.

Portfolio highlights

• Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
• Valar Labs — AI to Make Oncologists Smarter
• Imaginecare — Imaginecare is a self-care support that helps patients with long-term health challenges to a better life. Imaginecare consists of a technical platform supplemented with a range of services and analysis tools that together offer a complete solution for healthcare.

Portfolio highlights

• Mosh — MOSH is a mission-focused, family-run company to get you thinking more about your brain health! Try our MOSH bars formulated with superfoods & vital brain nutrients.
• Scent Lab — A hyper-personalized approach to fragrance. We leverage data & science in our Scent Discovery Quiz to curate your perfect scent and personalized candle.
• Alba Health — Discover your baby's gut health & microbiome for the best start in life.

Portfolio highlights

• ÄIO — Innovative food technologies to replace palm oil, coconut oil and animal fats with sustainable and healthier alternatives.
• Alba Health — Discover your baby's gut health & microbiome for the best start in life.
• Quantagonia — Advanced quantum algorithms, for your most important business problems, delivering breakthrough performance on today's high-performance computers, with seamless migration for later use on quantum computers.

Portfolio highlights

• Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
• porkchop — In-space logistics for SmallSats in Low Earth Orbit and beyond.
• Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.

Portfolio highlights

• Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
• Ligna Energy — Ligna Energy is a green-tech start-up company developing disruptive technology and products for large-scale stationary electrical energy storage. The battery technology is made from cheap forest-based materials and organic polymers in combination with a water-based electrolyte. This is a unique solution foundation - enabling the world to shifttowards a fossil free energy system.

Portfolio highlights

• Estrid — Estrid is an online portal that offers women's personal care products.
• Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
• Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.

Portfolio highlights

• Epishine — Epishine's goal is to be able to provide the world's most scalable, resource efficient, and affordable solar modules. Epishine sells light energy harvesting modules to manufacturers of wireless products. The modules are used to harvest light in any lighting conditions, turning light into usable power.
• Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative proximity ligation assay -based solutions for spatial proteomics.

Portfolio highlights

• PolicyBoss — PolicyBoss provides free online insurance quotes, where the customer can get a free quote and buy insurance policy. We have a range of products from a large selection of insurance companies.PolicyBoss is one of India’s largest retail broking firm in motor insurance.Advantage to take insurance from PolicyBoss, is that we offer online add-onservices & convenient and easy online payment process.
• Fibe (Formerly EarlySalary) — Get instant loans up to Rs. 5L with tenures up to 24 months & rates as low as 2.5% p.m. Check your eligibility now.
• Dr. Agarwal's — Dr. Agarwals eye hospital with best eye specialist and 135+ hospitals in India providing best eye disease treatment since 1957. Book an appointment now!

Portfolio highlights

• GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
• SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
• Sol Voltaics — Founded in 2007, Sol Voltaics AB is a venture-backed, development-stage nanotechnology company focused on development and commercialization of highly efficient, third-generation photovoltaic concentrator solar cells based on its proprietary heterostructured nanowire epitaxial growth and process technologies.

Portfolio highlights

• Silecs — PiBond manufactures materials used in electronic devices, including patterning materials for semiconductors and optical materials. We also develop complete solutions that allow our clients to focus on creating innovative products.
• SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
• Action Pharma — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.

Portfolio highlights

• Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative proximity ligation assay -based solutions for spatial proteomics.

Portfolio highlights

• Gedea Biotech — Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as wellas providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.

Portfolio highlights

• Elastisys — Elastisys provides fully-managed Kubernetes Platform as a Service, GDPR-ready on EU clouds with optional PostgreSQL, RabbitMQ, and Redis.
• Future Ordering — From Future Ordering.
• Once Upon Publishing — The new way to make photo books.

Portfolio highlights

• Cantargia — The company is based on the original discovery that leukemic stem cells in patients with chronic myeloid leukemia (CML) express a cell-surface receptor, whereas corresponding normal hematopoietic stem cells do not express this receptor. Stem cells from patients with acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) has also beenshown to have and upregulation of the receptor. Cantargia uses this receptor, the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia

Portfolio highlights

• Mycorena — Fungi-based, next-generation vegan protein. A food manufacturing solution superior to plants, using significantly less resources.

Portfolio highlights

• Wrapp — THE NEW STANDARD HAS ARRIVED. Wrapp is The New Standard for rewarding purchases and customer loyalty. The end to an era of irrelevant advertising and outdated memberships. Wrapp connects to our users’ payment cards, and analyzes transactions to learn their buying behavior. This way, our users only get rewards from brands they're interestedin. And by sticking to cashback returns, we make sure they get rewards they actually find useful. Simply put, we put purchasing power in the hands of consumers, and meaningful marketing in the hands of brands.
• Altris — Altris is a leading developer of sodium-ion batteries, offering superior performance and sustainability. Our innovative energy storage solutions are made from abundant and renewable materials, revolutionizing the way we power the world. Discover our cutting-edge technology today.
• Vindmark — Innovativ effektiv vindkraft

Portfolio highlights

• Mariana Oncology — Mariana Oncology is a biotechnology research industry.
• Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
• Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is

Portfolio highlights

• VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
• Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
• ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.

Portfolio highlights

• Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
• Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
• Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Portfolio highlights

• Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative proximity ligation assay -based solutions for spatial proteomics.

Portfolio highlights

• nyris — Our custom search engines make it easy for people to find products, spare parts, and components for industry and eCommerce
• NORNORM — NORNORM is a subscription-based furnishing model, letting your business adapt to the needs of tomorrow. Beautiful, affordable and fully circular.
• Impossible Materials — Enabling sustainable products

Portfolio highlights

• Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
• THE PACK — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
• Swedish Temptations — Swedish Temptations, founded in 2019 by CEO Pia Qvarnström, built a brand named Bärta for producing organic, vegan and fermented food. The ingredients include Swedish split peas.

Portfolio highlights

• Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.

Portfolio highlights

• ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
• Mojo — Laboratory-grade AI-powered semen test at home. Test your sperm count, motility, volume and concentration with the Mojo kit. Check your fertility from home at low cost.
• Volta Greentech — Battling global warming by reducing methane emissions from cows